Akso Health (AHG) Non-Current Deffered Revenue (2019 - 2020)
Akso Health (AHG) posted quarterly Non-Current Deffered Revenue of $96228.0 for Q1 2020, down 49.34% year-on-year from $189958.0 in Q2 2019, and down 38.04% on a QoQ basis from $155300.0 in Q3 2019.
Akso Health (AHG) Non-Current Deffered Revenue (2019 - 2020) Analysis & Trends
Akso Health (AHG) has reported Non-Current Deffered Revenue for 2 consecutive years, with $96228.0 the latest figure, recorded in Q1 2020.
- Quarterly Non-Current Deffered Revenue fell 49.34% year-over-year to $96228.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $96228.0 (down 49.34% YoY) and the FY2020 annual result came in at $96228.0, down 49.34% from the prior year.
- Non-Current Deffered Revenue declined to $96228.0 in Q1 2020 per AHG's latest filing, from $155300.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for AHG reached as high as $189958.0 in Q1 2019 and fell as low as $96228.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | - |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | - |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | - |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | - |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | - |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | - |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 1.06 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 96,228.00 |
| Sep 30, 2019 | 155,300.00 |
| Mar 31, 2019 | 189,958.00 |